Huh-7 cell line as an alternative cultural model for the production of human like erythropoietin (EPO)

Journal of Translational Medicine

Volumn 9, Issue 1, 2011, Pages

  Kausar, Humera ^a   Gull, Sana ^a   Ijaz, Bushra ^a   Ahmad, Waqar ^a   Sarwar, Muhammad T ^a   Iqbal, Zafar ^b   Nawaz, Zafar ^c   Riazuddin, Sheikh ^a   Hassan, Sajida ^a  

^a UNIVERSITY OF THE PUNJAB   (Pakistan)

^b RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^c UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

Author keywords

Chinese hamster ovary cell line; huh 7; Epo; Erythropoietin; cho; Human hepatoma cell line; pcr; Polymerase chain reaction

Indexed keywords

COMPLEMENTARY DNA; DNA FRAGMENT; RECOMBINANT ERYTHROPOIETIN; ERYTHROPOIETIN; RECOMBINANT PROTEIN; SIGNAL PEPTIDE;

AMINO ACID SEQUENCE; ANIMAL CELL; ARTICLE; CHO CELL; COMPARATIVE STUDY; CONTROLLED STUDY; CYTOMEGALOVIRUS; DRUG SYNTHESIS; ENZYME LINKED IMMUNOSORBENT ASSAY; ERYTHROPOIETIN GENE; EXPRESSION VECTOR; FEMALE; GENE; HEPATOMA CELL; HUH 7 CELL LINE; HUMAN; HUMAN CELL; IMMUNOCHEMISTRY; KOZAK SEQUENCE; NONHUMAN; PROMOTER REGION; PROTEIN EXPRESSION; PROTEIN FOLDING; PROTEIN GLYCOSYLATION; PROTEIN PROCESSING; PROTEIN SECRETION; PROTEIN SYNTHESIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SEQUENCE ANALYSIS; TRANSIENT EXPRESSION; TRANSIENT TRANSFECTION; WESTERN BLOTTING; ANIMAL; BIOLOGICAL MODEL; BIOSYNTHESIS; CRICETULUS; EXTRACELLULAR SPACE; GENETICS; HAMSTER; INTRACELLULAR SPACE; METABOLISM; MOLECULAR GENETICS; NUCLEOTIDE SEQUENCE; PLASMID; POLYMERASE CHAIN REACTION; REPRODUCIBILITY; TUMOR CELL LINE;

ANIMALS; BASE SEQUENCE; CELL LINE, TUMOR; CHO CELLS; CRICETINAE; CRICETULUS; DNA, COMPLEMENTARY; ERYTHROPOIETIN; EXTRACELLULAR SPACE; HUMANS; INTRACELLULAR SPACE; MODELS, BIOLOGICAL; MOLECULAR SEQUENCE DATA; PLASMIDS; POLYMERASE CHAIN REACTION; PROTEIN SORTING SIGNALS; RECOMBINANT PROTEINS; REPRODUCIBILITY OF RESULTS;

EID: 80055062529     PISSN: None     EISSN: 14795876     Source Type: Journal    
DOI: 10.1186/1479-5876-9-186     Document Type: Article

References (28)

1. Jelkmann W. Erythropoietin: structure, control of production, and function. Physiol Rev 1992, 72:449-489.
2. Lai PH, Everett R, Wang FF, Arakawa T, Goldwasser E. Structural characterization of human erythropoietin. J Biol Chem 1986, 261:3116-3121.
3. Wasley LC, Timony G, Murtha P, Stoudemire J, Dorner AJ, Caro J, Krieger M, Kaufman RJ. The importance of N- and O-linked oligosaccharides for the biosynthesis and in vitro and in vivo biologic activities of erythropoietin. Blood 1991, 77:2624-2632.
4. Jacobson LO, Goldwasser E, Fried W, Plzak L. Role of the kidney in erythropoiesis. Nature 1957, 179:633-634. 10.1038/179633a0, 13418752.
5. Eschbach JW, Egrie JC, Downing MR, Browne JK, Adamson JW. Correction of the anemia of end-stage renal disease with recombinant human erythropoietin. Results of a combined phase I and II clinical trial. N Engl J Med 1987, 316:73-78. 10.1056/NEJM198701083160203, 3537801.
6. Henry DH, Bowers P, Romano MT, Provenzano R. Epoetin alfa. Clinical evolution of a pleiotropic cytokine. Arch Intern Med 2004, 164:262-276. 10.1001/archinte.164.3.262, 14769622.
7. Reuter G, Gabius HJ. Eukaryotic glycosylation: whim of nature or multipurpose tool?. Cell Mol Life Sci 1999, 55:368-422. 10.1007/s000180050298, 10228555.
8. Sheeley DM, Merrill BM, Taylor LC. Characterization of monoclonal antibody glycosylation: comparison of expression systems and identification of terminal alpha-linked galactose. Anal Biochem 1997, 247:102-110. 10.1006/abio.1997.2036, 9126378.
9. Schweikart F, Jones R, Jaton JC, Hughes GJ. Rapid structural characterisation of a murine monoclonal IgA alpha chain: heterogeneity in the oligosaccharide structures at a specific site in samples produced in different bioreactor systems. J Biotechnol 1999, 69:191-201. 10.1016/S0168-1656(99)00039-5, 10361726.
10. Cointe D, Beliard R, Jorieux S, Leroy Y, Glacet A, Verbert A, Bourel D, Chirat F. Unusual N-glycosylation of a recombinant human erythropoietin expressed in a human lymphoblastoid cell line does not alter its biological properties. Glycobiology 2000, 10:511-519. 10.1093/glycob/10.5.511, 10764840.
11. Yuen CT, Storring PL, Tiplady RJ, Izquierdo M, Wait R, Gee CK, Gerson P, Lloyd P, Cremata JA. Relationships between the N-glycan structures and biological activities of recombinant human erythropoietins produced using different culture conditions and purification procedures. Br J Haematol 2003, 121:511-526. 10.1046/j.1365-2141.2003.04307.x, 12716378.
12. Irie A, Suzuki A. The molecular basis for the absence of N-glycolylneuraminic acid in humans. Tanpakushitsu Kakusan Koso 1998, 43:2404-2409.
13. Zhu A, Hurst R. Anti-N-glycolylneuraminic acid antibodies identified in healthy human serum. Xenotransplantation 2002, 9:376-381. 10.1034/j.1399-3089.2002.02138.x, 12371933.
14. Durocher Y, Butler M. Expression systems for therapeutic glycoprotein production. Curr Opin Biotechnol 2009, 20:700-707. 10.1016/j.copbio.2009.10.008, 19889531.
15. Tuch BE, Szymanska B, Yao M, Tabiin MT, Gross DJ, Holman S, Swan MA, Humphrey RK, Marshall GM, Simpson AM. Function of a genetically modified human liver cell line that stores, processes and secretes insulin. Gene Ther 2003, 10:490-503. 10.1038/sj.gt.3301911, 12621453.
16. Simpson AM, Szymanska B, Tuch BE, Marshall GM. Secretion and storage of insulin from a human hepatoma cell line (HUH7-INS). Transplant Proc 1999, 31:812. 10.1016/S0041-1345(98)01782-5, 10083351.
17. Maxwell PH, Ferguson DJ, Nicholls LG, Iredale JP, Pugh CW, Johnson MH, Ratcliffe PJ. Sites of erythropoietin production. Kidney Int 1997, 51:393-401. 10.1038/ki.1997.52, 9027712.
18. Schmidt FR. Recombinant expression systems in the pharmaceutical industry. Appl Microbiol Biotechnol 2004, 65:363-372. 10.1007/s00253-004-1656-9, 15480623.
19. Lin FK, Suggs S, Lin CH, Browne JK, Smalling R, Egrie JC, Chen KK, Fox GM, Martin F, Stabinsky Z, et al. Cloning and expression of the human erythropoietin gene. Proc Natl Acad Sci USA 1985, 82:7580-7584. 10.1073/pnas.82.22.7580, 391376, 3865178.
20. Stenstrom CM, Holmgren E, Isaksson LA. Cooperative effects by the initiation codon and its flanking regions on translation initiation. Gene 2001, 273:259-265. 10.1016/S0378-1119(01)00584-4, 11595172.
21. Blobel G, Dobberstein B. Transfer of proteins across membranes. I. Presence of proteolytically processed and unprocessed nascent immunoglobulin light chains on membrane-bound ribosomes of murine myeloma. J Cell Biol 1975, 67:835-851. 10.1083/jcb.67.3.835, 2111658, 811671.
22. Kozak M. Initiation of translation in prokaryotes and eukaryotes. Gene 1999, 234:187-208. 10.1016/S0378-1119(99)00210-3, 10395892.
23. Zhang F, Dong L, Cai M, Shen J, Wang Y. Heterologous expression of lipoprotein-associated phospholipase A2 in different expression systems. Protein Expr Purif 2006, 48:300-306.
24. Grabenhorst E, Schlenke P, Pohl S, Nimtz M, Conradt HS. Genetic engineering of recombinant glycoproteins and the glycosylation pathway in mammalian host cells. Glycoconj J 1999, 16:81-97. 10.1023/A:1026466408042, 10612409.
25. Meex SJ, Andreo U, Sparks JD, Fisher EA. Huh-7 or HepG2 cells: which is the better model for studying human apolipoprotein-B100 assembly and secretion?. J Lipid Res 2011, 52:152-158. 10.1194/jlr.D008888, 20956548.
26. Chung B, Matak P, McKie AT, Sharp P. Leptin increases the expression of the iron regulatory hormone hepcidin in HuH7 human hepatoma cells. J Nutr 2007, 137:2366-2370.
27. Sorensen CM, Hansen TK, Steffensen R, Jensenius JC, Thiel S. Hormonal regulation of mannan-binding lectin synthesis in hepatocytes. Clin Exp Immunol 2006, 145:173-182. 10.1111/j.1365-2249.2006.03101.x, 1942004, 16792688.
28. Chung B, Verdier F, Matak P, Deschemin JC, Mayeux P, Vaulont S. Oncostatin M is a potent inducer of hepcidin, the iron regulatory hormone. FASEB J 2010, 24:2093-2103. 10.1096/fj.09-152561, 20124431.